Results of the German IPEP study evaluating the tolerability, efficacy, and acceptance of fulvestrant (Faslodex(r)) under routine clinical conditions in advanced breast cancer
M. Warm, A. Thomas, K. Ziegler, C. Moers, R. Kates, N. HarbeckVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70582-2
File:
PDF, 55 KB
english, 2008